SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-019410
Filing Date
2020-04-29
Accepted
2020-04-29 06:42:28
Documents
7
Period of Report
2020-06-08
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A urgn-def14a_20200608.htm DEF 14A 1154982
2 GRAPHIC gpxd3z5hjrv3000004.jpg GRAPHIC 4377
3 GRAPHIC gpxd3z5hjrv3000006.jpg GRAPHIC 75642
4 GRAPHIC gpxd3z5hjrv3000003.jpg GRAPHIC 3531
5 GRAPHIC gpxd3z5hjrv3000001.jpg GRAPHIC 7136
6 GRAPHIC gpxd3z5hjrv3000002.jpg GRAPHIC 2627
7 GRAPHIC gpxd3z5hjrv3000005.jpg GRAPHIC 75148
  Complete submission text file 0001564590-20-019410.txt   1388905
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38079 | Film No.: 20827238
SIC: 2834 Pharmaceutical Preparations